Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome
Clinical trial NCT04355689 · COMPLETED
Trial details
- NCT number
- NCT04355689
- Sponsor
- Nacuity Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-03
- Primary completion
- 2025-06-20
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.